Publication | Open Access

First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models

Neurodegenerative DiseasesMedicineNeuroendocrine MechanismNeuropeptide ReceptorNeuropharmacologyNeurodegenerative ModelsFirst-in-class Thyrotropin-releasing HormoneNeuroscienceNeurologyThyroid HormoneEndocrinologyPharmacologyNeurochemistryNeuropeptides